Current Clinical Trials on Stem Cell Therapy for Duchenne
Clinical trials test the safety and efficacy of a new medical procedure or compound against the outcome in similarly situated patients who do not receive them. Stem cell trials have been conducted on numerous diseases and ailments including cancers, cardiac damage from heart attack and disease, Alzheimer's, Parkinson's Diseases, stroke, and traumatic injuries. Some of theses diseases are now treated clinically with stem cell therapy as the international medical community recognizes the benefits of this therapy option.
There are an increasing number of clinical trials using stem cells therapy to treat Duchenne Muscular Dystrophy (DMD). These trials include both human and animal studies. Historical results and ongoing research on stem cell therapies for DMD patients show immense promise for intermediate therapy and eventual restoration of dystrophin in DMD patients.
Clinical trials may represent a therapeutic option as well. They can point the way to what the future of therapy may be, and in what time frame.
For more about current U.S. National Institute of Health (NIH) stem cell clinical trials for Duchenne muscular dystrophy click HERE